Search Results 251-260 of 20698 for Multiple sclerosis
Patients with progressive forms of multiple sclerosis (MS) have limited. therapeutic options and require new, effective treatments. Ocrelizumab, an.
... multiple sclerosis (MS), with which it is commonly confused. The test uses live cells to identify patients who are positive for an antibody to MOG. Mayo ...
Multiple sclerosis. Multiple sclerosis is a disease in which your autoimmune system attacks the myelin sheath covering nerve fibers in your brain. In people ...
muscular dystrophy and multiple sclerosis (MS). Muscular dystrophy is a group of diseases that cause progressive weakness and loss of muscle mass. In muscular ...
A Study of New MRI Markers to Detect the Earliest Phases of Pediatric Multiple Sclerosis · More about research at Mayo Clinic · Mayo Clinic Footer.
Maher became involved in multiple sclerosis (MS) research through an invitation from Mayo Clinic neurologists. They asked him to conceive and supervise an ...
... multiple sclerosis. People diagnosed with relapsing forms of multiple sclerosis are eligible for enrollment as long as they meet all the inclusion criteria ...
Two such diseases are muscular dystrophy and multiple sclerosis (MS). On the next Mayo Clinic Radio program, Dr. Jennifer Martinez-Thompson, a Mayo Clinic ...
Wingerchuk evaluates and treats multiple sclerosis, neuromyelitis optica spectrum disorder, also known as NMOSD or Devic disease, myelin oligodendrocyte ...
The purpose of this study is to better identify the long term benefit to risk profile of tecfidera in patients with multiple sclerosis who are prescribed ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.